CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 250464-250640
Annnotations
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1944 | 0-176 | Sentence | denotes | Doripenem also completed a phase 3 trial versus piperacillin/tazobactam for HAP (including early-onset VAP), and a phase 3 trial versus imipenem for VAP (early and late onset). |
| T71649 | 0-176 | Sentence | denotes | Doripenem also completed a phase 3 trial versus piperacillin/tazobactam for HAP (including early-onset VAP), and a phase 3 trial versus imipenem for VAP (early and late onset). |
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T43 | 0-176 | Sentence | denotes | Doripenem also completed a phase 3 trial versus piperacillin/tazobactam for HAP (including early-onset VAP), and a phase 3 trial versus imipenem for VAP (early and late onset). |